Jupiter Asset Management Ltd. Purchases New Stake in McKesson Corporation $MCK

Jupiter Asset Management Ltd. acquired a new position in shares of McKesson Corporation (NYSE:MCK) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 96,921 shares of the company’s stock, valued at approximately $74,875,000. Jupiter Asset Management Ltd. owned 0.08% of McKesson at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of MCK. Norges Bank acquired a new stake in shares of McKesson during the second quarter worth approximately $1,346,661,000. Alliancebernstein L.P. lifted its position in McKesson by 150.4% in the 2nd quarter. Alliancebernstein L.P. now owns 2,268,015 shares of the company’s stock worth $1,661,956,000 after buying an additional 1,362,386 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its stake in shares of McKesson by 56.4% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,236,536 shares of the company’s stock valued at $906,109,000 after buying an additional 446,060 shares during the period. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main boosted its stake in shares of McKesson by 45.6% during the 2nd quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 833,780 shares of the company’s stock valued at $610,977,000 after buying an additional 261,296 shares during the period. Finally, Acadian Asset Management LLC grew its holdings in shares of McKesson by 68.0% during the 2nd quarter. Acadian Asset Management LLC now owns 636,596 shares of the company’s stock valued at $466,441,000 after acquiring an additional 257,670 shares in the last quarter. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Insider Transactions at McKesson

In related news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of McKesson stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $955.00, for a total transaction of $313,240.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Leann B. Smith sold 190 shares of the business’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total value of $179,550.00. Following the transaction, the executive vice president owned 2,989 shares in the company, valued at $2,824,605. This represents a 5.98% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 794 shares of company stock worth $718,056. 0.08% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

MCK has been the subject of several recent research reports. Morgan Stanley reiterated an “overweight” rating and set a $966.00 price objective on shares of McKesson in a report on Thursday, January 29th. Zacks Research downgraded shares of McKesson from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 25th. Mizuho upped their price target on McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. Barclays raised their price objective on McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a research note on Wednesday. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of McKesson in a research report on Wednesday, December 10th. Thirteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, McKesson has a consensus rating of “Moderate Buy” and an average price target of $943.50.

McKesson Stock Down 1.0%

MCK opened at $937.19 on Friday. The stock’s 50 day moving average price is $850.99 and its two-hundred day moving average price is $794.10. The firm has a market capitalization of $114.80 billion, a P/E ratio of 26.95, a price-to-earnings-growth ratio of 1.52 and a beta of 0.40. McKesson Corporation has a 12-month low of $594.34 and a 12-month high of $971.93.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating the consensus estimate of $9.19 by $0.15. The company had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.McKesson’s revenue for the quarter was up 11.4% compared to the same quarter last year. During the same period in the prior year, the business earned $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, analysts anticipate that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be given a $0.82 dividend. This represents a $3.28 annualized dividend and a yield of 0.3%. The ex-dividend date is Monday, March 2nd. McKesson’s dividend payout ratio (DPR) is currently 9.43%.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.